These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 17010200)
21. Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. Byrne C; Colditz GA; Willett WC; Speizer FE; Pollak M; Hankinson SE Cancer Res; 2000 Jul; 60(14):3744-8. PubMed ID: 10919644 [TBL] [Abstract][Full Text] [Related]
22. No relationship between circulating levels of sex steroids and mammographic breast density: the Prospect-EPIC cohort. Verheus M; Peeters PH; van Noord PA; van der Schouw YT; Grobbee DE; van Gils CH Breast Cancer Res; 2007; 9(4):R53. PubMed ID: 17692133 [TBL] [Abstract][Full Text] [Related]
23. Levels of C-peptide and mammographic breast density. Diorio C; Pollak M; Byrne C; Mâsse B; Hébert-Croteau N; Yaffe M; Coté G; Bérubé S; Brisson J Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2661-4. PubMed ID: 16284393 [TBL] [Abstract][Full Text] [Related]
25. Plasma leptin levels, LEPR Q223R polymorphism and mammographic breast density: a cross-sectional study. Dallal C; Garte S; Ragin C; Chen J; Lloyd S; Modugno F; Weissfeld J; Taioli E Int J Biol Markers; 2013 Jun; 28(2):161-7. PubMed ID: 23564622 [TBL] [Abstract][Full Text] [Related]
26. The effect of transdermal testosterone on mammographic density in postmenopausal women not receiving systemic estrogen therapy. Davis SR; Hirschberg AL; Wagner LK; Lodhi I; von Schoultz B J Clin Endocrinol Metab; 2009 Dec; 94(12):4907-13. PubMed ID: 19850682 [TBL] [Abstract][Full Text] [Related]
27. The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study. Greendale GA; Palla SL; Ursin G; Laughlin GA; Crandall C; Pike MC; Reboussin BA Am J Epidemiol; 2005 Nov; 162(9):826-34. PubMed ID: 16177147 [TBL] [Abstract][Full Text] [Related]
28. Physical activity, mammographic density, and age-related lobular involution among premenopausal and postmenopausal women. Hanna M; Dumas I; Jacob S; Têtu B; Diorio C Menopause; 2015 Sep; 22(9):964-75. PubMed ID: 25710783 [TBL] [Abstract][Full Text] [Related]
29. A randomized, placebo-controlled trial (NCIC CTG MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal women. Cigler T; Tu D; Yaffe MJ; Findlay B; Verma S; Johnston D; Richardson H; Hu H; Qi S; Goss PE Breast Cancer Res Treat; 2010 Apr; 120(2):427-35. PubMed ID: 19967558 [TBL] [Abstract][Full Text] [Related]
30. Association of diet and mammographic breast density in the Minnesota breast cancer family cohort. Vachon CM; Kushi LH; Cerhan JR; Kuni CC; Sellers TA Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):151-60. PubMed ID: 10698475 [TBL] [Abstract][Full Text] [Related]
31. Mammographic density in relation to daidzein-metabolizing phenotypes in overweight, postmenopausal women. Frankenfeld CL; McTiernan A; Aiello EJ; Thomas WK; LaCroix K; Schramm J; Schwartz SM; Holt VL; Lampe JW Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1156-62. PubMed ID: 15247126 [TBL] [Abstract][Full Text] [Related]
32. Mammographic densities during the menopausal transition: a longitudinal study of Australian-born women. Guthrie JR; Milne RL; Hopper JL; Cawson J; Dennerstein L; Burger HG Menopause; 2007; 14(2):208-15. PubMed ID: 17091098 [TBL] [Abstract][Full Text] [Related]
33. Hormone therapy use and mammographic density in postmenopausal Norwegian women. Couto E; Qureshi SA; Hofvind S; Hilsen M; Aase H; Skaane P; Vatten L; Ursin G Breast Cancer Res Treat; 2012 Feb; 132(1):297-305. PubMed ID: 22052325 [TBL] [Abstract][Full Text] [Related]
34. Metabolic and hormonal profiles: HDL cholesterol as a plausible biomarker of breast cancer risk. The Norwegian EBBA Study. Furberg AS; Jasienska G; Bjurstam N; Torjesen PA; Emaus A; Lipson SF; Ellison PT; Thune I Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):33-40. PubMed ID: 15668473 [TBL] [Abstract][Full Text] [Related]
35. Premenopausal insulin-like growth factor-I serum levels and changes in breast density over menopause. Verheus M; Peeters PH; Kaaks R; van Noord PA; Grobbee DE; van Gils CH Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):451-7. PubMed ID: 17372240 [TBL] [Abstract][Full Text] [Related]
36. Affinity proteomic profiling of plasma for proteins associated to area-based mammographic breast density. Byström S; Eklund M; Hong MG; Fredolini C; Eriksson M; Czene K; Hall P; Schwenk JM; Gabrielson M Breast Cancer Res; 2018 Feb; 20(1):14. PubMed ID: 29444691 [TBL] [Abstract][Full Text] [Related]
37. Endometriosis and mammographic density measurements in the Nurses' Health Study II. Farland LV; Tamimi RM; Eliassen AH; Spiegelman D; Bertrand KA; Missmer SA Cancer Causes Control; 2016 Oct; 27(10):1229-37. PubMed ID: 27549771 [TBL] [Abstract][Full Text] [Related]
38. Circulating levels of inflammatory markers and mammographic density among postmenopausal women. Reeves KW; Weissfeld JL; Modugno F; Diergaarde B Breast Cancer Res Treat; 2011 Jun; 127(2):555-63. PubMed ID: 21069450 [TBL] [Abstract][Full Text] [Related]
39. Reproductive factors related to childbearing and mammographic breast density. Yaghjyan L; Colditz GA; Rosner B; Bertrand KA; Tamimi RM Breast Cancer Res Treat; 2016 Jul; 158(2):351-9. PubMed ID: 27351801 [TBL] [Abstract][Full Text] [Related]
40. Associations of mammographic density with dietary factors in Japanese women. Nagata C; Matsubara T; Fujita H; Nagao Y; Shibuya C; Kashiki Y; Shimizu H Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2877-80. PubMed ID: 16365004 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]